Monday - August 25, 2025
QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics
June 04, 2025
SAN DIEGO, California, June 4 -- Quidel Corp., a provider of in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, issued the following news release:

* * *

QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics

Company Intends to Acquire LEX Diagnostics Upon U.S. FDA Clearance

Company Plans to Discontinue Savanna Platform Development

Company Reaffirms Ful . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products